Camber Capital Management

Camber Capital Management as of Dec. 31, 2016

Portfolio Holdings for Camber Capital Management

Camber Capital Management holds 35 positions in its portfolio as reported in the December 2016 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Gilead Sciences (GILD) 9.4 $179M 2.5M 71.61
Teva Pharmaceutical Industries (TEVA) 8.9 $171M 4.7M 36.25
Mylan Nv 8.3 $158M 4.1M 38.15
Stryker Corporation (SYK) 6.3 $120M 1.0M 119.81
Allergan 6.0 $114M 543k 210.01
Perrigo Company (PRGO) 5.3 $101M 1.2M 83.23
Select Medical Holdings Corporation (SEM) 4.2 $80M 6.0M 13.25
Nektar Therapeutics (NKTR) 3.9 $74M 6.0M 12.27
Genomic Health 3.8 $72M 2.5M 29.39
Brookdale Senior Living (BKD) 3.6 $68M 5.5M 12.42
Myriad Genetics (MYGN) 3.5 $68M 4.1M 16.67
Endo International (ENDPQ) 3.4 $64M 3.9M 16.47
Cardiovascular Systems 3.2 $61M 2.5M 24.21
Alkermes (ALKS) 2.9 $56M 1.0M 55.58
Vertex Pharmaceuticals Incorporated (VRTX) 2.9 $55M 750k 73.67
Orthofix International Nv Com Stk 2.8 $54M 1.5M 36.18
Livanova Plc Ord (LIVN) 2.8 $54M 1.2M 44.97
Biogen Idec (BIIB) 2.6 $50M 175k 283.58
Universal American 2.5 $49M 4.9M 9.95
Amgen (AMGN) 2.3 $44M 300k 146.21
Abbott Laboratories 2.0 $38M 1.0M 38.41
CONMED Corporation (CNMD) 1.7 $33M 750k 44.17
athenahealth 1.6 $32M 300k 105.17
AMAG Pharmaceuticals 1.1 $21M 611k 34.80
Endologix 1.1 $21M 3.6M 5.72
Syneron Medical Ltd ord 1.0 $20M 2.3M 8.40
Invitae (NVTA) 1.0 $19M 2.4M 7.94
Centene Corporation (CNC) 0.6 $11M 200k 56.51
BioScrip 0.6 $11M 10M 1.04
Arena Pharmaceuticals 0.3 $6.0M 4.3M 1.42
Protalix Biotherapeutics Inc note 4.500% 9/1 0.2 $4.6M 9.0M 0.51
Catabasis Pharmaceuticals 0.2 $3.6M 1.0M 3.61
Targacept Inc Conv Dtd convertible 0.1 $1.7M 1.7M 1.00
Dextera Surgical 0.0 $804k 838k 0.96
Biolase Inc warrants 0.0 $0 7.2M 0.00